Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

Ryerson University

$25,000.00

Development of synthetic organic chemistry methods to selectively transform steroid derivatives to access known metabolites and impurities, and novel drug-like structures

FY 2019-20

Summary
Dalton Pharma Services is a leading manufacturer of pharmaceutical products and provider of analytical services to the pharmaceutical and biotechnological industries. Dalton is particularly interested in steroid compounds because of the high demand for standards, metabolites, and impurities from customers for their research and development needs. They are currently facing a technological problem in efficiently making certain classes of steroid compounds.This collaborative project between Dalton Pharma and Prof. Marc J. Adler's lab at Ryerson University seeks to discover new chemical methods to selectively transform molecules of biological interest, including steroids. The specific goal is to develop highly specific ways to reduce ketones to secondary alcohols, allowing for the differentiation of two ketones in a steroid molecules with similar reactivity profiles; this selective reactivity is vital to make particular subsets of steroid analogues. Currently differentiation requires a multi-step synthetic process, resulting in significant chemical waste, expenditure of time, and decrease in product yield. We aim to directly differentiate the two functional groups for chemical transformation, thus providing a more efficient and greener path to the desired products. Such products include known metabolites of and impurities in drugs. This method will also provide ready access to new bioactive molecules to be evaluated as potential probes or therapeutics. The collaborative project will train two Master's students who will develop innovative and industrially relevant chemical synthesis methods in close collaboration with Dalton Pharma scientists.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
543543-2019
Name nom
Adler, Marc
Department département
Chemistry and Biology
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3700
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic chemistry
Research subject fr
Chimie organique
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Development of synthetic organic chemistry methods to selectively transform steroid derivatives to access known metabolites and impurities, and novel drug-like structures
Keyword
NSERC
Application summary
Dalton Pharma Services is a leading manufacturer of pharmaceutical products and provider of analytical services to the pharmaceutical and biotechnological industries. Dalton is particularly interested in steroid compounds because of the high demand for standards, metabolites, and impurities from customers for their research and development needs. They are currently facing a technological problem in efficiently making certain classes of steroid compounds.This collaborative project between Dalton Pharma and Prof. Marc J. Adler's lab at Ryerson University seeks to discover new chemical methods to selectively transform molecules of biological interest, including steroids. The specific goal is to develop highly specific ways to reduce ketones to secondary alcohols, allowing for the differentiation of two ketones in a steroid molecules with similar reactivity profiles; this selective reactivity is vital to make particular subsets of steroid analogues. Currently differentiation requires a multi-step synthetic process, resulting in significant chemical waste, expenditure of time, and decrease in product yield. We aim to directly differentiate the two functional groups for chemical transformation, thus providing a more efficient and greener path to the desired products. Such products include known metabolites of and impurities in drugs. This method will also provide ready access to new bioactive molecules to be evaluated as potential probes or therapeutics. The collaborative project will train two Master's students who will develop innovative and industrially relevant chemical synthesis methods in close collaboration with Dalton Pharma scientists.
Ryerson University - $25,000 Grant (2019-20) | Canada Spends